Pulmonary embolism (PE) is the third most common cause of death in the United States, with an estimated 100,000 deaths and over 780,000 clinically apparent cases diagnosed annually.[@b1-vhrm-6-317] Results of autopsy studies have indicated that most cases of venous thromboembolism (VTE) go undiagnosed, even when they are the immediate cause of death. When PE is missed on initial presentation, a delay of 24 hours, during which anticoagulation occurs, increases the risk of recurrent embolism from 4% to 23%, and leads to a fivefold increase in the likelihood of death within a year.[@b2-vhrm-6-317] Traditional examinations used to detect PE are generally expensive and are not able to be carried out in all hospitals, which increases difficulty of access.

In the search for a cost-effective screening approach to PE, ELISA D-dimer (DD) testing shows promise, often sparing patients unnecessary radiation and expense. However, DD has limitations, and gaining an understanding of these limitations in practice is vital. Additionally, measuring the volumetric capnography (VCap) associated with arterial blood gas analysis (ABGA), is an alternative to traditional examinations.

In this case report we present the results of clinical score (Wells), DD (Vidas^®^), and the VCap variables of a patient diagnosed with PE who was submitted for clinical treatment (dicoumarin). The DD, VCap, and image exams were conducted following admission to the hospital and again eight months after discharge ([Table 1](#t1-vhrm-6-317){ref-type="table"}).

Case report
===========

Our case study was a 25-year-old male smoker, who had symptoms of medium level dyspnea for one year. He was sent to a referral center for further investigation and underwent a transthoracic echocardiogram, which revealed "straddling thrombus", or a moderate dilation of the chambers on the right side of the heart; additionally, his pulmonary artery systolic pressure was estimated at 78 mmHg and pulmonary artery diastolic pressure was estimated at 22 mmHg. Following the transthoracic echocardiogram, he was admitted to hospital based on a preliminary diagnosis of PE and treatment of anticoagulation with heparin was started.

In the physical examination the patients was found to be in generally good health. He was conscious, alert, dyspneic (22 bpm), had cyanosis of the extremities, a heart rate 88, arterial pressure of 150/110 mmHg, and did not have edema or tightening of the lower limbs. A pretest (Wells' score) revealed there was a moderate probability that the patient had PE. ABGA in room air revealed PaO~2~ = 66.2; PaCO~2~ = 28.9 mmHg; and SpO~2~ = 98%.

Pulmonary scintigraphy showed heterogeneous distribution of perfusion in both lungs.

The ELISA DD levels were determined (VIDAS^®^ D-dimer; bioMérieux, France); this test has a cutoff of \<500 ng/mL. The sample taken on admission to the hospital was negative for PE (339.54 ng/mL; false-negative). The Doppler echocardiogram of the lower limbs showed no thrombi.

Respiratory dead space and functional space were determined through VCap (CO~2~SMO PLUS 8100^®^; Dixtal/Novametrix, Brazil) associated with ABGA (Radiometer ABL^®^ 700 Series; Radiometer Medical ApS, Denmark). The indices derived from these values were the end-tidal alveolar dead space fraction (AVDSf), the late dead space fraction (fDlate), and arterial-end-tidal CO~2~ gradient \[P(a-et)CO~2~\] ([Table 1](#t1-vhrm-6-317){ref-type="table"}).

After a history of more than two weeks of development and maintaining clinical and hemodynamic stability, we suspected repeated and extensive PE, but chemical thrombolysis did not show improvement. A pulmonary arteriogram revealed the patient had normal coronary arteries; ventriculography showed an ejection fraction of LV of 69%; important bulging in the abdominal region; amputation was present in peripheral branches, suggestive of multiple chronic emboli; and thrombus was located in the inferior lobe of the left lung, along with hypoperfusion of the middle segment in the lung right.

Eight months after the patient was discharged, a new lung scintigraphy (control), ELISA DD, and VCap were carried out. In comparison with the first round of tests, this scintigraphy revealed a discreet improvement in the perfusion pattern in the apical, anterior, posterior, and superior segments of the patient's right lung. The DD result was 157.96 ng/mL. The ABGA in room air revealed PaO~2~ = 70.0 mmHg, PaCO~2~ = 30.0 mmHg, and SpO~2~ = 99%.

The association of VCap variables with ABGA allows for the calculation of several indices, the variations of which can infer the presence of occlusion or improve after treatment of pulmonary vessels.[@b3-vhrm-6-317]--[@b5-vhrm-6-317]

We determined the following parameters: AVDSf: PaCO~2~ -- PetCO2/PaCO~2~;[@b6-vhrm-6-317]fDlate = PaCO~2~ -- Pet(15% CPT)CO~2~/PaCO~2~;[@b7-vhrm-6-317]P(a-et)CO~2~: PaCO~2~ -- PetCO~2~.[@b8-vhrm-6-317]

The calculation of fDlate attempts to avoid differences introduced in the functional dead space value by height, gender, and age. The use of an estimated tidal volume also eliminates the effect of the respiratory rate on tidal volume. In addition, the mathematical extrapolation of phase III of the CO~2~ expirogram at 15% of the total lung capacity (TLC) is aimed at bringing PetCO~2~ and PaCO~2~ into closer proximity. The TLC was obtained using the method devised by Grimby et al.[@b9-vhrm-6-317]

Discussion
==========

When an episode of PE occurs, the imbalance in the ventilation/perfusion ratio is increased, and, consequently, the variables which form the functional dead space are altered. In the literature, we observe the following higher cut-off values for the studied variables: 0.15 for AVDSf,[@b6-vhrm-6-317] 0.12 for fDlate,[@b7-vhrm-6-317] and 5 mmHg for P(a-et)CO~2~.[@b8-vhrm-6-317] Considering the fact that a higher calculated value indicates greater obstruction of the vascular system (and a larger alveolar dead space), we infer that there is a correlation between the extent of the area without perfusion and the value obtained.[@b3-vhrm-6-317]--[@b5-vhrm-6-317] In this patient, the result of VCap variations were displayed in imaging results.

Breen et al[@b10-vhrm-6-317] in a similar case report, albeit without follow-up and VCap, described a patient with acute PE with a similarly negative ELISA DD result (495.1 ng/mL). Ray et al[@b11-vhrm-6-317] using the same methodology ELISA (VIDAS^®^), obtained 12 false-negative results for patients with DVT or PE interned in emergency services. So, in rare cases where the symptoms are present over a long period of time, D-dimers might have become negative. However, results of our study show that there is an attenuate for this situation: the association of a clinical pre-test + DD with VCap. Again, it should be emphasized that the association of noninvasive exams is essential (enhance sensibility).

It is known that when dealing with PE, anticoagulation is aimed at reducing the possibility of a new embolic phenomenon, as well as reducing the mortality risk. Therefore, imaging tests are requested whenever there is clinical suspicion of PE. In spite of the fact that the diagnostic work-up for chronic PE is not the same as that for acute PE, noninvasive methods that rule out the possibility of PE would reduce the number of patients unnecessarily undergoing imaging tests.

Conclusions
===========

In summary, we have presented the case of a patient with diagnosis of PE, which was confirmed through imaging tests and with altered pulmonary functional variables obtained through VCap tests. These variables followed the results of image exams throughout clinical intervention, highlighting the importance of VCap as a potential noninvasive tool when used in association with measures of DD levels and clinical pretests. In rare situations, in patients with clinical pretest result suggesting moderate or high probability for PE, but with a negative DD result, an alternative test could be the VCap. Our results indicate it must be performed twice because in our case study the first time it paralleled the important vascular obstruction, and the second time it showed the absence of improvement. In this way we have demonstrated that VCap is a very interesting noninvasive tool to appreciate the vascular obstruction of a chronic thromboembolic disease.
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###### 

VCap variables in admission and follow-up

                  **D-Dimer**    **AVDSf**   **fDLate**   **P(a-et)CO**~**2**~**(mmHg)**
  --------------- -------------- ----------- ------------ --------------------------------
  Cut-off         \<500 ng/mL    0.15        0.12         5.0
  Admission       339.54 ng/mL   0.42        0.38         12.0
  Post-8 months   157.96 ng/mL   0.34        0.31         10.2

**Abbreviations:**

AVDSf, (end-tidal) alveolar dead space fraction;

Fdlate, late dead space fraction;

P(a-et)CO~2~, arterial-end-tidal gradient of CO~2.~
